Here's Why Albemarle (ALB) Fell More Than Broader Market
Werte in diesem Artikel
The latest trading session saw Albemarle (ALB) ending at $85.23, denoting a -0.99% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily loss of 0.22%. Meanwhile, the Dow lost 0.36%, and the Nasdaq, a tech-heavy index, lost 0.16%.The the stock of specialty chemicals company has fallen by 16.11% in the past month, lagging the Basic Materials sector's loss of 9.71% and the S&P 500's loss of 2.36%.Market participants will be closely following the financial results of Albemarle in its upcoming release. On that day, Albemarle is projected to report earnings of -$0.36 per share, which would represent a year-over-year decline of 119.46%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.4 billion, down 40.44% from the year-ago period.It's also important for investors to be aware of any recent modifications to analyst estimates for Albemarle. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Albemarle presently features a Zacks Rank of #3 (Hold).In terms of valuation, Albemarle is presently being traded at a Forward P/E ratio of 46.53. This expresses a premium compared to the average Forward P/E of 13.41 of its industry.We can also see that ALB currently has a PEG ratio of 2.91. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Chemical - Diversified industry currently had an average PEG ratio of 0.89 as of yesterday's close.The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 210, which puts it in the bottom 17% of all 250+ industries.The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com.Just Released: Zacks Top 10 Stocks for 2024Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Albemarle Corporation (ALB): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Albemarle
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Albemarle
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Albemarle Corp.
Analysen zu Albemarle Corp.
Datum | Rating | Analyst | |
---|---|---|---|
16.11.2017 | Albemarle Hold | Deutsche Bank AG | |
10.11.2017 | Albemarle Outperform | RBC Capital Markets | |
09.11.2017 | Albemarle Neutral | UBS AG | |
27.10.2017 | Albemarle Outperform | BMO Capital Markets | |
25.09.2017 | Albemarle Neutral | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
10.11.2017 | Albemarle Outperform | RBC Capital Markets | |
27.10.2017 | Albemarle Outperform | BMO Capital Markets | |
08.05.2017 | Albemarle Outperform | RBC Capital Markets | |
17.03.2017 | Albemarle Outperform | RBC Capital Markets | |
01.03.2017 | Albemarle Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
16.11.2017 | Albemarle Hold | Deutsche Bank AG | |
09.11.2017 | Albemarle Neutral | UBS AG | |
25.09.2017 | Albemarle Neutral | Robert W. Baird & Co. Incorporated | |
10.03.2016 | Albemarle Neutral | Seaport Global Securities | |
03.02.2015 | Albemarle Market Perform | Cowen and Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
16.08.2011 | Albemarle underperform | Oppenheimer & Co. Inc. | |
04.01.2006 | Update Albemarle Corp.: Underweight | JP Morgan |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Albemarle Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen